TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
European Drug Testing Service EDTS AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
86,274
|
84,169
|
78,471 |
Financial expenses |
71
|
92
|
310 |
Earnings before taxes |
11,897
|
2,911
|
-2,018 |
EBITDA |
10,919
|
3,075
|
-1,192 |
Total assets |
71,759
|
64,041
|
66,493 |
Current assets |
71,594
|
63,551
|
65,537 |
Current liabilities |
17,075
|
19,621
|
20,807 |
Equity capital |
53,709
|
44,097
|
45,510 |
- share capital |
232
|
231
|
251 |
Employees (average) |
27
![]() |
27
|
31 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
74.8%
|
68.9%
|
68.4% |
Turnover per employee |
3,195
|
3,117
|
2,531 |
Profit as a percentage of turnover |
13.8%
|
3.5%
|
-2.6% |
Return on assets (ROA) |
16.7%
|
4.7%
|
-2.6% |
Current ratio |
419.3%
|
323.9%
|
315.0% |
Return on equity (ROE) |
22.2%
|
6.6%
|
-4.4% |
Change turnover |
1,672
|
12,054
|
5,893 |
Change turnover % |
2%
|
17%
|
8% |
Chg. No. of employees |
0
|
-4
|
2 |
Chg. No. of employees % |
0%
|
-13%
|
7% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.